本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Enliven Treateutics

20.51
+0.66003.32%
盘后20.510.00000.00%17:43 EDT
成交量:22.12万
成交额:452.71万
市值:10.05亿
市盈率:-10.84
高:20.79
开:19.95
低:19.65
收:19.85
数据加载中...
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]